Table 1 Relationship between uH2B expression and clinicopathological parameters in LUAD.
Clinicopathological variables | n | uH2B | χ2 | P | |
|---|---|---|---|---|---|
Low expression | High expression | ||||
(n = 139) | (n = 24) | ||||
Gender | |||||
 Male | 92 | 81 | 11 | 1.288 | 0.256 |
 Female | 71 | 58 | 13 | ||
Age(years) | |||||
 < 60 | 68 | 57 | 11 | 0.196 | 0.658 |
 ≥ 60 | 95 | 82 | 13 | ||
Smoking | |||||
 YES | 78 | 69 | 9 | 1.209 | 0.272 |
 NO | 85 | 70 | 15 | ||
T staging | |||||
 T1 + T2 | 104 | 85 | 19 | 2.287 | 0.09 |
 T3 + T4 | 59 | 54 | 5 | ||
N staging | |||||
 NO + N1 | 98 | 81 | 17 | 1.34 | 0.246 |
 N2 + N3 | 65 | 58 | 7 | ||
M staging | |||||
 MO | 155 | 132 | 23 | 0.033 | 0.856 |
 M1 | 8 | 7 | 1 | ||
Clinical staging | |||||
 I + II | 81 | 64 | 17 | 5.031 | 0.025 * |
 III + IV | 82 | 75 | 7 | ||
Recurrence | |||||
 YES | 38 | 37 | 1 | 5.771 | 0.016* |
 NO | 125 | 102 | 23 | ||
EGFR | |||||
 Fusion | 46 | 40 | 6 | 0.143 | 0.205 |
 Unfused | 64 | 54 | 10 | ||